Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration.

Parente, F; Bargiggia, S; Prada, A; Bortoli, A; Giacosa, A; Germanà, B; Ferrari, A; Casella, G; De Pretis, G; Miori, G

Parente, F; Bargiggia, S; Prada, A; Bortoli, A; Giacosa, A; Germanà, B; Ferrari, A; Casella, G; De Pretis, G; Miori, G.

Affiliation

Parente F; Gastrointestinal Unit, Gastroenterology and Digestive Endoscopy Division, Ospedale "A. Manzoni", Via dell'Eremo 9/11, 23900, Lecco, Italy, f.parente@ospedale.lecco.it.

Int J Colorectal Dis ; 28(10): 1423-31, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23754545

Subject(s)

Diverticulitis/drug therapy; Diverticulitis/prevention & control; Mesalamine/therapeutic use; Adult; Aged; Aged, 80 and over; Confidence Intervals; Demography; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Mesalamine/adverse effects; Middle Aged; Pilot Projects; Placebos; Recurrence; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesalamine / Diverticulitis Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Colorectal Dis Journal subject: GASTROENTEROLOGIA Year: 2013 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google